Patent US2205230A successfully refreshed from Google Patents.
Patent US4598317A successfully refreshed from Google Patents.
Patent JPS526887A successfully refreshed from Google Patents.
Patent US4538228A successfully refreshed from Google Patents.
Patent US2031119A successfully refreshed from Google Patents.
Patent US2428866A successfully refreshed from Google Patents.
Patent US4471113A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4471113A Expired / Lapsed US ⏱️ 0.0 years remaining

Prodrugs based on phospholipid-nucleoside conjugates

Assignee: ENERGY United States, Department of
•
Filing: 1982-02-03
•
Granted: 1984-09-11
•
Expires: 2002-02-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to the production of a single diastereomeric form of a phospholipid araC conjugate as a prodrug.

Inventors

  • 👤 Malcolm MacCoss

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 15:27
CPC Classifications
C; C07; C07H; C07H23/00; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/16; C07H19/20

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 129 words
A method for producing a pure diastereomer of the following phospholipid-araC conjugate ##STR10## from a first compound ##STR11## where x and y are integers from 12-16, said process comprising the steps of: (a) reacting the first compound with t-butyldimethylsilyl chloride under silylation conditions to produce a second compound ##STR12## (b) reacting the second compound with levulinic anhydride under acylating conditions to produce a third compound ##STR13## where Lv is the levulinyl group (c) deblocking the third compound to produce a fourth compound ##STR14## (d) condensing the fourth compound with ##STR15## to produce a fifth compound ##STR16## (e) deblocking the fifth compound to produce a sixth compound as a mixture of diastereomers at phosphorous: ##STR17## (f) and hydrolyzing the sixth compound to produce said monophosphate-linked derivative as a single diastereomer.
Claim 2
Independent Claim 129 words
A method for producing a pure diastereomer of the following phospholipid-araC conjugate ##STR10## from a first compound ##STR11## where x and y are integers from 12-16, said process comprising the steps of: (a) reacting the first compound with t-butyldimethylsilyl chloride under silylation conditions to produce a second compound ##STR12## (b) reacting the second compound with levulinic anhydride under acylating conditions to produce a third compound ##STR13## where Lv is the levulinyl group (c) deblocking the third compound to produce a fourth compound ##STR14## (d) condensing the fourth compound with ##STR15## to produce a fifth compound ##STR16## (e) deblocking the fifth compound to produce a sixth compound as a mixture of diastereomers at phosphorous: ##STR17## (f) and hydrolyzing the sixth compound to produce said monophosphate-linked derivative as a single diastereomer.
Claim 3
Dependent Claim 13 words
The process of claim 1 wherein x and y are equal to 14.
Claim 4
Dependent Claim 48 words
A mixture of the single diastereomer ##STR18## where x and y are integers from 12-16, and the single diastereomer of the following compound ##STR19## where a and b are integers from 12-16, said diastereomers being present respectively, in a weight ratio in the order of 1:2 to 3:1.
Claim 5
Dependent Claim 48 words
A mixture of the single diastereomer ##STR18## where x and y are integers from 12-16, and the single diastereomer of the following compound ##STR19## where a and b are integers from 12-16, said diastereomers being present respectively, in a weight ratio in the order of 1:2 to 3:1.
Claim 6
Dependent Claim 16 words
The mixture of claim 3 wherein x and y and a and b each equal 14.
Claim 7
Dependent Claim 13 words
The mixture of claim 3 characterized by being soluble in a saline solution.

References Cited (Backward Citations)

US4096324A Cited
US4291024A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-09-11 1988-03-12 1988-09-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-09-11 1992-03-12 1992-09-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-09-11 1996-03-12 1996-09-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag